SCOTTSDALE, Ariz. — More than 51,000 units of adult and children’s toothpaste and mouthwash sold across the United States have been recalled after federal regulators detected hormones in product samples, according to reports from Fox Business and Medical Daily.
The voluntary recall by Scottsdale, Arizona-based ORL Labs LLC affects 51,762 units across six ORL Organic Oral Care products, Fox Business reported. Testing conducted by the Food and Drug Administration revealed the presence of progesterone, estradiol, or dehydroepiandrosterone, commonly known as DHEA, in samples of the oral hygiene products.
The recall initially began on Oct. 12 and was formally categorized as a Class II event by the FDA on Nov. 6. The federal agency applies a Class II designation when exposure to a noncompliant product may lead to temporary or medically reversible adverse health consequences, or when the likelihood of severe harm is remote.
Affected Oral Care Products
No illnesses or adverse health events have been reported to date in connection with the recalled items, Medical Daily reported. The affected merchandise was distributed to retailers nationwide and features expiration dates spanning between September 2026 and August 2028.
According to FDA documentation cited by Fox Business, the recall includes three distinct formulations of 4-ounce natural toothpaste tubes:
- Fresh Mint, comprising 19,247 units with UPC 850006245499
- Cinnamint, comprising 7,202 units with UPC 850006245512
- Bubblegum Kids, comprising 3,976 units with UPC 850006245505
The action also applies to three 16.9-ounce mouthwash varieties:
- Fresh Mint, comprising 12,081 units with UPC 850006245451
- Cinnamint Kids, comprising 6,140 units with UPC 850006245468
- Bubblegum Kids, comprising 3,116 units with UPC 850006245475
Progesterone and estradiol act as primary female sex steroidal hormones that help regulate body metabolism and reproduction, while DHEA is an adrenal precursor hormone that the human body can transform into estrogen and testosterone, according to reporting by NTD News and Medical Daily.
Contamination Background and Consumer Guidance
ORL Labs attributed the presence of the hormones to cross-contamination, Medical Daily reported. The FDA enforcement notice did not disclose specific hormone concentrations detected in individual product lots or detail the precise mechanism behind the cross-contamination, Fox Business reported.
The incident follows a previous hormone-related recall in December 2025 involving ORL products, Medical Daily reported. An FDA warning letter issued in January 2026 cited shared production equipment at a Phoenix facility that had not been adequately validated to prevent cross-contamination between oral care products and hormone supplements.
Health experts recommend that households currently using any of the six affected ORL products stop using them immediately. Consumers can check lot numbers printed on product packaging against the complete lists published in the FDA enforcement report, and affected items can be discarded or returned to retailers to seek a refund, Medical Daily reported.



